Inventor · disambiguated record
Tom Vink
Also filed as: VINK TOM
26 granted patents·24 pending applications·406 citations·filing 2002–2025
97Inventor score
Top patents by PatentIndex Score
50 records- 0198US11542323B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Jan 3, 2023·6 cites·24 claims
- 0298US11524995B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Dec 13, 2022·6 cites·20 claims
- 0397US11866514B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2020·Granted Jan 9, 2024·5 cites·37 claims
- 0497US11421024B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2020·Granted Aug 23, 2022·6 cites·23 claims
- 0597US10800836B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2016·Granted Oct 13, 2020·10 cites·10 claims
- 0697US10647764B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 12, 2020·9 cites·14 claims
- 0797US10647763B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 12, 2020·9 cites·14 claims
- 0897US10640554B2Agents, uses and methods for the treatment of synucleinopathyH LUNDBECK AS·Filed 2019·Granted May 5, 2020·9 cites·14 claims
- 0997US10597464B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2017·Granted Mar 24, 2020·35 cites·12 claims
- 1097US9150663B2Heterodimeric antibody Fc-containing proteins and methods for production thereofLABRIJN ARAN FRANK·Filed 2011·Granted Oct 6, 2015·119 cites·37 claims
- 1196US10364285B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 30, 2019·13 cites·9 claims
- 1296US10358484B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·13 cites·9 claims
- 1396US10358483B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·13 cites·9 claims
- 1495US10906991B2Bispecific antibodies and methods for production thereofGENMAB AS·Filed 2015·Granted Feb 2, 2021·15 cites·6 claims
- 1595US10358482B2Antibodies for the treatment of synucleinopathyH LUNDBECK AS·Filed 2017·Granted Jul 23, 2019·11 cites·9 claims
- 1694US9212230B2Bispecific antibodies and methods for production thereofSCHUURMAN JANINE·Filed 2008·Granted Dec 15, 2015·54 cites·29 claims
- 1793US9944711B2Antibodies against human CD38GENMAB AS·Filed 2016·Granted Apr 17, 2018·16 cites·48 claims
- 1891US9249226B2Antibodies against human CD38DE WEERS MICHEL·Filed 2011·Granted Feb 2, 2016·20 cites·52 claims
- 1990US9714297B2Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2015·Granted Jul 25, 2017·9 cites·29 claims
- 2090US9150658B2Human antibodies against tissue factor and methods of use thereofVERPLOEGEN SANDRA·Filed 2009·Granted Oct 6, 2015·20 cites·43 claims
- 2186US2024209117A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2023·Application pending·0 cites
- 2285US2023312693A1Agents, Uses and Methods for the Treatment of SynucleinopathyH LUNDBECK AS·Filed 2022·Application pending·0 cites
- 2382US10351629B2Recombinant IgG4 monovalent antibodiesGENMAB AS·Filed 2016·Granted Jul 16, 2019·2 cites·24 claims
- 2482US2023416403A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2022·Application pending·0 cites
- 2579US9322035B2Recombinant IgG4 monovalent antibodiesSCHUURMAN JANINE·Filed 2008·Granted Apr 26, 2016·2 cites·6 claims
- 2679US2025340669A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2025·Application pending·0 cites
- 2778US10752695B2Stable IgG4 antibodiesGENMAB AS·Filed 2016·Granted Aug 25, 2020·1 cites·11 claims
- 2873US10155816B2Recombinant monovalent antibodies and methods for production thereofPARREN PAUL·Filed 2006·Granted Dec 18, 2018·1 cites·17 claims
- 2973US2022204636A1Antibodies against human cd38GENMAB AS·Filed 2021·Application pending·0 cites
- 3072US2022396629A1Recombinant monovalent antibodies and methods for production thereofGENMAB AS·Filed 2022·Application pending·0 cites
- 3169US2021171657A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2020·Application pending·0 cites
- 3267US2021061919A1STABLE IgG4 ANTIBODIESGENMAB AS·Filed 2020·Application pending·0 cites
- 3366US9580506B2Potency assays for antibody drug substance binding to an Fc receptorGERARDA HAVENITH CATHARINA EMANUELE·Filed 2006·Granted Feb 28, 2017·2 cites·104 claims
- 3466US2023076417A1Multispecific antigen-binding molecule with improved internalization characteristicsGENMAB AS·Filed 2022·Application pending·0 cites
- 3565US2022177585A1Potency assays for antibody drug substance binding to an fc receptorGENMAB AS·Filed 2021·Application pending·0 cites
- 3664US11230604B2Antibodies against human CD38GENMAB AS·Filed 2018·Granted Jan 25, 2022·0 cites·119 claims
- 3764US2019169311A1Human Antibodies Against Tissue Factor and Methods of Use ThereofGENMAB AS·Filed 2018·Application pending·0 cites
- 3862US2010267934A1Stable igg4 antibodiesGENMAB AS·Filed 2008·Application pending·0 cites
- 3961US2018044431A1Human antibodies against tissue factor and methods of use thereofGENMAB AS·Filed 2017·Application pending·0 cites
- 4058US2017362319A1Potency assays for antibody drug substance binding to an fc receptorGENMAB AS·Filed 2017·Application pending·0 cites
- 4157US2019169298A1Recombinant monovalent antibodies and methods for production thereofGENMAB AS·Filed 2018·Application pending·0 cites
- 4257US2013345406A1Stable igg4 antibodiesGENMAB AS·Filed 2013·Application pending·0 cites
- 4355US2016046727A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2015·Application pending·0 cites
- 4451US2010255012A1Recombinant fucose modified monovalent half-antibodies obtained by molecular engineeringGENMAB AS·Filed 2008·Application pending·0 cites
- 4549US2010325744A1Non-glycosylated recombinant monovalent antibodiesGENMAB AS·Filed 2008·Application pending·0 cites
- 4649US2011045007A1Fusion or linked proteins with extended half lifeGENMAB AS·Filed 2008·Application pending·0 cites
- 4749US2010291023A1Method for extending the half-life of exogenous or endogenous soluble moleculesGENMAB AS·Filed 2008·Application pending·0 cites
- 4847US2019352423A1Multispecific antigen-binding molecule with improved internalization characteristicsGENMAB AS·Filed 2017·Application pending·0 cites
- 4941US2002187932A1Treatment of anorexia nervosa and bulimiaFiled 2002·Application pending·0 cites
- 5034US2012020952A1Methods for producing mixtures of antibodiesPARREN PAUL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tom Vink files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →